July 14,2006
Chairman Grassley Questions CMS, FDA About Substituted Inhalation Drugs
Please see the printer-friendly version of Chairman Grassley's letter CMS and FDA regarding substituted inhalation drugs.
Next Article Previous Article
Recent News
- Crapo Statement at Executive Session to Vote on Tax Court Nominees
- Crapo Announces Finance Committee Staff Updates
- Crapo, Wyden Lead Bipartisan Senators in Urging USDA Action to Protect America’s Potato Crops
- Crapo, Wyden Introduce Bipartisan Bill to Improve Unemployment Insurance
- Crapo Statement at Tax Court Nominations